Interleukin Related
IL
Interleukins are a group of cytokines (secreted proteins and signaling molecules) that were first seen to be expressed by white blood cells (leukocytes). The function of the immune system depends in a large part on interleukins, and rare deficiencies of a number of them have been described, all featuring autoimmune diseases or immune deficiency. The majority of interleukins are synthesized by helper CD4 T lymphocytes, as well as through monocytes, macrophages, and endothelial cells. They promote the development and differentiation of T and B lymphocytes, and hematopoietic cells. Interleukin receptors on astrocytes in the hippocampus are also known to be involved in the development of spatial memories in mice.
Interleukin Related Isoform Specific Products
-
Interleukin Related
(949)
View all products
-
IL-1
(483)
View all products
-
IL-2
(116)
View all products
-
IL-3
(8)
View all products
-
IL-4
(89)
View all products
-
IL-5
(34)
View all products
-
IL-6
(506)
View all products
-
IL-8
(103)
View all products
-
IL-10
(95)
View all products
-
IL-12
(39)
View all products
-
IL-13
(56)
View all products
-
IL-15
(10)
View all products
-
IL-17
(107)
View all products
-
IL-23
(38)
View all products
-
IL-7
(15)
View all products
-
IL-33
(5)
View all products
-
IL-22
(11)
View all products
-
IL-18
(23)
View all products
All Product Categories
-
Interleukin Related Inhibitors
(1594)
View all products
-
Interleukin Related Agonists
(15)
View all products
-
Interleukin Related Antagonists
(33)
View all products
-
Interleukin Related Activators
(166)
View all products
-
Interleukin Related Modulators
(101)
View all products
-
Interleukin Related Chemicals
(2)
View all products
-
Interleukin Related Inducers
(62)
View all products
-
Interleukin Related Degraders
(2)
View all products
-
Interleukin Related Controls
(2)
View all products
-
Interleukin Related Ligands
(10)
View all products
-
IL-4 Proteins
(26)
View all products
-
IL-12 Proteins
(39)
View all products
-
IL-17 Proteins
(71)
View all products
-
IL-8/CXCL8 Proteins
(16)
View all products
-
Multi-CSF/IL-3 Proteins
(18)
View all products
-
IL-1 Proteins
(43)
View all products
-
IL-2 Proteins
(22)
View all products
-
IL-5 Proteins
(20)
View all products
-
IL-6 Proteins
(24)
View all products
-
IL-10 Proteins
(16)
View all products
-
IL-13 Proteins
(19)
View all products
-
IL-15 Proteins
(18)
View all products
-
IL-23 Proteins
(22)
View all products
-
Interleukin Related Related Products (2249)
Related Products (2249)
-
Recombinant Proteins (352)
-
Antibodies (36)
-
Interleukin Related Isoform Comparison
-
(±)-Praeruptorin A (Standard)
0 ImagesCat. No.: HY-N0081RCAS No.: 73069-25-7(±)-Praeruptorin A (Standard) is the analytical standard of (±)-Praeruptorin A (HY-N0081). This product is intended for research and analytical applications. (±)-Praeruptorin A, a coumarin compound, is the main bioactive component in Peucedani Radix. As a calcium channel blocker, (±)-Praeruptorin A exhibits great antihypertensive effects. In addition, (±)-Praeruptorin A also has the effects of relaxing vascular smooth muscle, inhibiting airway inflammation and airway hyperresponsiveness. (±)-Praeruptorin A can be used for the research of allergic asthma, hypertension and other diseases.
-
Isoeucommin A
0 ImagesCat. No.: HY-N19615CAS No.: 134859-90-8Isoeucommin A is a lignan compound. Isoeucommin A activates the Nrf2/HO-1 pathway and induces phosphorylation of GSK-3β. Isoeucommin A reduces the levels of pro-inflammatory cytokines TNF-α, IL-1β and IL-6, decreases the oxidative stress marker MDA, increases the antioxidants SOD and GSH, and alleviates oxidative stress in mesangial cells. Isoeucommin A alleviates renal tissue injury, improves impaired renal function and enhances the viability of renal tubular epithelial cells in diabetic nephropathy models. Isoeucommin A can be used in the research of diabetic nephropathy.
-
Ac-YVAD-CHO acetate
0 ImagesCat. No.: HY-120019ASynonyms: L-709049 acetateAc-YVAD-CHO (L-709049) acetate is a potent, reversible, specific tetrapeptide interleukin-lβ converting enzyme (ICE) inhibitor with mouse and human Ki values of 3.0 and 0.76 nM. Ac-YVAD-CHO acetate is also a caspase-1 inhibitor. Ac-YVAD-CHO acetate can suppress the production of mature IL-lβ.
-
Cyanidin 3,5-diglucoside chloride (Standard)
0 ImagesCat. No.: HY-129138RCAS No.: 2611-67-8Cyanidin 3,5-diglucoside (chloride) (Standard) is the analytical standard of Cyanidin 3,5-diglucoside (chloride) (HY-129138). This product is intended for research and analytical applications. Cyanidin 3,5-diglucoside chloride is an anthocyanin. Cyanidin 3,5-diglucoside chloride inhibits inflammatory cytokines (IL-1α, IL-1β, and IL-6) expression and NO production. Cyanidin 3,5-diglucoside chloride inhibits the phosphorylation of STAT3, IκB, ERK, p38, and AKT. Cyanidin 3,5-diglucoside chloride inhibits high pressure-induced decrease in GLAST. Cyanidin 3,5-diglucoside chloride exerts anti-inflammatory and skin barrier modulating effects. Cyanidin 3,5-diglucoside chloride can be used in retinal research.
-
ATP ditromethamine
0 ImagesCat. No.: HY-B2176DCAS No.: 102047-34-7Synonyms: Adenosine 5'-triphosphate ditromethamineATP (Adenosine 5'-triphosphate) ditromethamine is a central component of energy storage and metabolism in vivo. ATP ditromethamine provides the metabolic energy to drive metabolic pumps and serves as a coenzyme in cells. ATP ditromethamine is an important endogenous signaling molecule in immunity and inflammation. ATP ditromethamine can activate the NLRP3 inflammasome and induce IL-1β and chemokines secretion. ATP ditromethamine has anti-bacterial infection effects and can protect mice against bacterial infection in mice.
-
AhR/PDE4 modulator-1
0 ImagesCat. No.: HY-189218AhR/PDE4 modulator-1 is a AhR/PDE4D dual-target modulator, with an AhR agonistic EC50 of 0.11 μM and a PDE4D inhibitory IC50 of 2.12 μM. AhR/PDE4 modulator-1 activates the AhR-CYP1A1 signaling pathway, promotes AhR nuclear translocation, and upregulates downstream CYP1A1; it inhibits PDE4D activity, elevates intracellular cAMP levels, and activates the downstream cAMP-PKA-CREB signaling pathway. Topical administration of AhR/PDE4 modulator-1 exerts anti-inflammatory effects in the Imiquimod (HY-B0180)-induced psoriasis-like mouse model, alleviates epidermal hyperplasia and inflammatory infiltration, and suppresses the expression of IL-17A/F. AhR/PDE4 modulator-1 can be used in research related to psoriasis.
-
APX002
0 ImagesCat. No.: HY-P992023APX002 is an anti-IL-1β humanized monoclonal antibody that binds to IL-1β with an affinity of 1.99×10?10M. APX002 blocks IL-1β receptor binding, inhibits IL-1β-induced downstream cell signaling and biological effects.APX002 can be used for the research of rheumatoid arthritis, diabetes, gout, cryopyrin-associated periodic syndrome, chronic obstructive pulmonary disorder, atherosclerosis, vasculitis.
-
KZR-8445 TFA
0 ImagesCat. No.: HY-P10466AKZR-8445 TFA, a cyclic depsipeptide, is a client-selective Sec61 inhibitor. KZR-8445 TFA binds to the fully opened Sec61 lateral gate, blocks lumenal plug domain access, stabilizes lateral gate helices, traps select signal peptides, and disrupts secretory and membrane protein biogenesis. KZR-8445 TFA inhibits pro-inflammatory cytokine secretion in primary immune cells. KZR-8445 TFA inhibits SARS-CoV-2 replication, virus-induced cytotoxicity, and spike protein biogenesis. KZR-8445 TFA blocks disease progression in a mouse model of rheumatoid arthritis. KZR-8445 TFA can be used for the researches of rheumatoid arthritis and SARS-CoV-2 infection.
-
sEH/AChE-IN-5
0 ImagesCat. No.: HY-183341sEH/AChE-IN-5 is a selective, orally active and brain-penetrant acetylcholinesterase (AChE) and soluble epoxide hydrolase (sEH) dual inhibitor with IC50 values of 1.7 nM and 0.7 nM. sEH/AChE-IN-5 mediates neuroprotection and anti-inflammation via reduced TNF-α, IL-1β, IL-6, iNOS. sEH/AChE-IN-5 improves Scopolamine (HY-N0296)-induced learning and memory deficits mice. sEH/AChE-IN-5 can be used for the research of Alzheimer's disease.
-
SHP1-IN-2
0 ImagesCat. No.: HY-186140SHP1‑IN‑2 is a selective and orally active SHP1 inhibitor. SHP1‑IN‑2 covalently binds to Cys480 of SHP1. SHP1‑IN‑2 elicits potent antitumor immunity and suppresses syngeneic tumor growth. SHP1‑IN‑2 blocks tumor progression in a svngeneic cancer model by activating natural killer cells and cytotoxic CD8＋ T cells, along with reduced T cel l. SHP1‑IN‑2 can be used for cancer‑related research.
-
LAS194046
0 ImagesCat. No.: HY-150101CAS No.: 1798578-61-6LAS194046 is a selective pan-JAK inhibitor, with an IC50 of 5.46 nM against JAK1, 0.4 nM against JAK2, and 2.07 nM against JAK3. LAS194046 reduces the levels of IL-8 and MMP-9. LAS194046 enhances the activation of glucocorticoid response elements by Fluticasone propionate. LAS194046 inhibits T2-type allergic pulmonary inflammation, allergen-induced airway inflammation, and late-phase asthmatic responses in rats. LAS194046 can be used in research related to non-T2 severe asthma, chronic obstructive pulmonary disease, and asthma.
-
Il2 Mouse Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS06729Il2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Il2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
Difelikefalin acetate
0 ImagesCat. No.: HY-17609CCAS No.: 2803411-76-7Synonyms: CR-845 acetate; FE-202845 acetateDifelikefalin acetate (CR-845 acetate; FE-202845 acetate) is an orally active peripherally acting kappa opioid receptor agonist. Difelikefalin acetate reduces acute kidney injury, decreases oliguria, maintains urine flow, inhibits cytokine expression, and improves survival in endotoxemia after ischemia/reperfusion. Difelikefalin acetate suppresses pruritus signals and exhibits neuromodulatory antipruritic activity. Difelikefalin acetate can be used in research related to acute kidney injury, chronic kidney disease-associated pruritus, and atopic dermatitis.
-
Anti-inflammatory agent 107
0 ImagesCat. No.: HY-179502Anti-inflammatory agent 107 is an orally active anti-inflammatory agent. Anti-inflammatory agent 107 inhibits and NF-κB with a superior binding affinity of -9.4578 kcal/mol. Anti-inflammatory agent 107 reduces levels of inflammatory biomarkers (TNF-α, IL-6, INF-γ, NF-κβ, C-reactive protein and Erythrocyte Sedimentation Rate) and enhances the endogenous antioxidant defense system by elevating SOD (Superoxide Dismutase), CAT (Catalase) and GSH (Glutathione) activities. Anti-inflammatory agent 107 not induces liver toxicity and demonstrates hepatoprotective effects. Anti-inflammatory agent 107 dose-dependently ameliorates leukocyte infiltration and tissue edema. Anti-inflammatory agent 107 can be used for anti-inflammatory research.
-
Anti-IL-10Rα Antibody
0 ImagesCat. No.: HY-P992037
-
IL5 Human Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS06770IL5 Human Pre-designed siRNA Set A contains three designed siRNAs for IL5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
KZR-8445
0 ImagesCat. No.: HY-P10466CAS No.: 2377734-91-1KZR-8445, a cyclic depsipeptide, is a client-selective Sec61 inhibitor. KZR-8445 binds to the fully opened Sec61 lateral gate, blocks lumenal plug domain access, stabilizes lateral gate helices, traps select signal peptides, and disrupts secretory and membrane protein biogenesis. KZR-8445 inhibits pro-inflammatory cytokine secretion in primary immune cells. KZR-8445 inhibits SARS-CoV-2 replication, virus-induced cytotoxicity, and spike protein biogenesis. KZR-8445 blocks disease progression in a mouse model of rheumatoid arthritis. KZR-8445 can be used for the researches of rheumatoid arthritis and SARS-CoV-2 infection.
-
XKH001
0 ImagesCat. No.: HY-P992486XKH001 is a recombinant humanized IgG1 monoclonal antibody targeting IL-25. XKH001 has low immunogenicity. XKH001 can be used for the research of type 2 inflammatory diseases.
-
MBL-1
0 ImagesCat. No.: HY-N6189CAS No.: 1815632-13-3MBL-1 is an orally active anti-inflammatory agent. MBL-1 can be isolated from the fermentation broth of Aspergillus sp. derived from gorgonians. MBL-1 inhibits the activity of the hCOX-2 protein with an IC50 of 5.77 μM. MBL-1 reduces the production of key pro-inflammatory mediators such as NO, ROS, IL-1β and IL-18 by inhibiting the MAPK/NF-κB and NLRP3 signaling pathways. MBL-1 exerts a protective effect against DSS-induced colitis. MBL-1 can be used for the research of ulcerative colitis.
